Nonmotor Manifestations in Parkinson Disease

被引:71
作者
Bernal-Pacheco, Oscar [2 ]
Limotai, Natlada [2 ,3 ,4 ]
Go, Criscely L. [5 ]
Fernandez, Hubert H. [1 ]
机构
[1] Cleveland Clin, Ctr Neurol Restorat, 9500 Euclid Ave,U-2, Cleveland, OH 44195 USA
[2] Univ Militar Nueva Granada, Neurol Clin, Bogota, Colombia
[3] Chulalongkorn Univ Hosp, Chulalongkorn Comprehens Movement Disorders Ctr, Bangkok, Thailand
[4] Thai Red Cross Soc, Bangkok, Thailand
[5] Univ Santo Tomas Hosp, Dept Neurol, Manila, Philippines
关键词
nonmotor symptom; Parkinson; dementia; behavioral; psychiatric; sleep disorders; autonomic dysfunction; SLEEP BEHAVIOR DISORDER; RESTLESS LEGS SYNDROME; IMPULSE CONTROL DISORDERS; EXCESSIVE DAYTIME SLEEPINESS; QUALITY-OF-LIFE; DOUBLE-BLIND; REM-SLEEP; RISK-FACTORS; VISUAL HALLUCINATIONS; PSYCHOTIC SYMPTOMS;
D O I
10.1097/NRL.0b013e31823d7abb
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Although the diagnosis of Parkinson disease (PD) still relies mainly on the appearance of its classical motor features of resting tremor, rigidity, bradykinesia, and postural instability, nonmotor manifestations in PD are now recognized as an integral component of this multisystem disorder. Review Summary: Nonmotor complications in PD occur commonly. The current understanding of cognitive dysfunction; neuropsychiatric manifestations including psychosis, impulsive control, and compulsive disorders, depression, anxiety and apathy; autonomic complications such as hypotension, erectile dysfunction, and urinary complications; sleep disorders and other nonmotor manifestations are summarized in this review. Conclusion: Nonmotor complications often carry a greater impact than motor features in PD. Therefore, hightened awareness and proper recognition of these features are critical in improving a Parkinson patient's quality of life.
引用
收藏
页码:1 / 16
页数:16
相关论文
共 288 条
[1]   Prevalence and characteristics of dementia in Parkinson disease - An 8-year prospective study [J].
Aarsland, D ;
Andersen, K ;
Larsen, JP ;
Lolk, A ;
Kragh-Sorensen, P .
ARCHIVES OF NEUROLOGY, 2003, 60 (03) :387-392
[2]   Prevalence and clinical correlates of psychotic symptoms in Parkinson disease - A community-based study [J].
Aarsland, D ;
Larsen, JP ;
Cummings, JL ;
Laake, K .
ARCHIVES OF NEUROLOGY, 1999, 56 (05) :595-601
[3]   Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial [J].
Aarsland, Dag ;
Ballard, Clive ;
Walker, Zuzana ;
Bostrom, Fredrik ;
Alves, Guido ;
Kossakowski, Katja ;
Leroi, Iracema ;
Pozo-Rodriguez, Francisco ;
Minthon, Lennart ;
Londos, Elisabet .
LANCET NEUROLOGY, 2009, 8 (07) :613-618
[4]   Excessive daytime sleepiness and subsequent development of Parkinson disease [J].
Abbott, RD ;
Ross, GW ;
White, LR ;
Tanner, CM ;
Masaki, KH ;
Nelson, JS ;
Curb, JD ;
Petrovitch, H .
NEUROLOGY, 2005, 65 (09) :1442-1446
[5]   Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease [J].
Adler, CH ;
Caviness, JN ;
Hentz, JG ;
Lind, M ;
Tiede, J .
MOVEMENT DISORDERS, 2003, 18 (03) :287-293
[6]   Severe constipation in Parkinson's disease relieved by botulinum toxin [J].
Albanese, A ;
Maria, G ;
Bentivoglio, A ;
Brisinda, G ;
Cassetta, E ;
Tonali, P .
MOVEMENT DISORDERS, 1997, 12 (05) :764-766
[7]   Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome [J].
Allen, R ;
Becker, PM ;
Bogan, R ;
Schmidt, M ;
Kushida, CA ;
Fry, JM ;
Poceta, JS ;
Winslow, D .
SLEEP, 2004, 27 (05) :907-914
[8]  
[Anonymous], 2005, Diagnostic and coding manual, P148
[9]   Randomized study of sertraline and low-dose amitriptyline in patients with Parkinson's disease and depression: Effect on quality of life [J].
Antonini, Angelo ;
Tesei, Silvana ;
Zecchinelli, Anna ;
Barone, Paolo ;
De Gaspari, Danilo ;
Canesi, Margherita ;
Sacilotto, Giorgio ;
Meucci, Nicoletta ;
Mariani, Claudio ;
Pezzoli, Gianni .
MOVEMENT DISORDERS, 2006, 21 (08) :1119-1122
[10]   Behavioural Adverse Effects of Dopaminergic Treatments in Parkinson's Disease Incidence, Neurobiological Basis, Management and Prevention [J].
Antonini, Angelo ;
Cilia, Roberto .
DRUG SAFETY, 2009, 32 (06) :475-488